PNC Financial Services Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $76.3K | Sell |
|
|||||
|
2025
Q2 | $83.9K | Buy |
|
|||||
|
2025
Q1 | $74.1K | Sell |
|
|||||
|
2024
Q4 | $67.8K | Buy |
|
|||||
|
2024
Q3 | $46.4K | Sell |
|
|||||
|
2024
Q2 | $103K | Sell |
|
|||||
|
2024
Q1 | $247K | Sell |
|
|||||
|
2023
Q4 | $320K | Buy |
|
|||||
|
2023
Q3 | $218K | Sell |
|
|||||
|
2023
Q2 | $375K | Sell |
|
|||||
|
2023
Q1 | $774K | Buy |
|
|||||
|
2022
Q4 | $584K | Sell |
|
|||||
|
2022
Q3 | $1.24M | Buy |
|
|||||
|
2022
Q2 | $1.34M | Buy |
|
|||||
|
2022
Q1 | $1.52M | Sell |
|
|||||
|
2021
Q4 | $1.61M | Buy |
|
|||||
|
2021
Q3 | $1.39M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Buy |
|
|||||
|
2021
Q1 | $1.38M | Buy |
|
|||||
|
2020
Q4 | $951K | Sell |
|
|||||
|
2020
Q3 | $1.03M | Buy |
|
|||||
|
2020
Q2 | $777K | Sell |
|
|||||
|
2020
Q1 | $525K | Buy |
|
|||||
|
2019
Q4 | $525K | Sell |
|
|||||
|
2019
Q3 | $1.72M | Sell |
|
|||||
|
2019
Q2 | $2.36M | Buy |
|
|||||
|
2019
Q1 | $1.09M | Sell |
|
|||||
|
2018
Q4 | $1.7M | Buy |
|
|||||
|
2018
Q3 | $30K | Sell |
|
|||||
|
2018
Q2 | $29K | Sell |
|
|||||
|
2018
Q1 | $169K | Sell |
|
|||||
|
2017
Q4 | $357K | Buy |
|
|||||
|
2017
Q3 | $293K | Buy |
|
|||||
|
2017
Q2 | $328K | Sell |
|
|||||
|
2017
Q1 | $351K | Sell |
|
|||||
|
2016
Q4 | $263K | Buy |
|
|||||
|
2016
Q3 | $231K | Sell |
|
|||||
|
2016
Q2 | $242K | Buy |
|
|||||
|
2016
Q1 | $277K | Buy |
|
|||||
|
2015
Q4 | $273K | Sell |
|
|||||
|
2015
Q3 | $260K | Sell |
|
|||||
|
2015
Q2 | $598K | Buy |
|
|||||
|
2015
Q1 | $422K | Buy |
|
|||||
|
2014
Q4 | $35K | Buy |
|
|||||
|
2014
Q3 | $37K | Buy |
|
|||||
|
2014
Q2 | $31K | Hold |
|
|||||
|
2014
Q1 | $23K | Sell |
|
|||||
|
2013
Q4 | $29K | Sell |
|
|||||
|
2013
Q3 | $36K | Buy |
|